Back to search

Japan· JP-6119400A2120

アルベカシン硫酸塩

A arbekacin product containing アルベカシン硫酸塩, registered in Japan by 日医工岐阜工場, on the national reimbursement list.

On Japan’s NHI price listATC J01GB12

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedアルベカシン硫酸塩ATCJ01GB12REGISTER NO.JP-6119400A2120PACKS LISTED0CHECKEDSeptember 25, 2026

The record

At a glance

MHLW / PMDA (Japan)
Active substance
アルベカシン硫酸塩
Manufacturer
日医工岐阜工場
Country
Japan (JP)
ATC code
J01GB12
ATC class
Arbekacin
Defined daily dose
0.2 g, P
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d5712f9b-0174-4d80-8207-f5d56bf2d371
GET /v1/drugs/d5712f9b-0174-4d80-8207-f5d56bf2d371?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "100mg2mL1管",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "6119400A2120",
  "category": "注射薬",
  "price_yen": 3592,
  "generic_name": "アルベカシン硫酸塩",
  "product_name_jp": null,
  "therapeutic_class": "6119",
  "transitional_expiry": null
}

See everything about arbekacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.